BACKGROUND: Anti- N-methyl-D-aspartate receptor (NMDAR) encephalitis is a severe autoimmune disorder characterized by high intrathecal antibody synthesis. Little is known about the long-term follow-up of the cerebrospinal fluid antibody status. OBJECTIVE: To describe persistent intrathecal antibody synthesis in a clinically healthy person 15 years after recovering from anti-NMDAR encephalitis. DESIGN: Case report. SETTING: Academic medical center. PATIENT: A 40-year-old woman who had been diagnosed as having encephalitis of unknown origin in 1995. MAIN OUTCOME MEASURES: Clinical evaluation and NMDAR antibody testing. RESULTS: On reexamination in 2011, the patient had fully recovered. Investigation of archived as well as follow-up serum and cerebrospinal fluid samples revealed intrathecal synthesis of NMDAR antibodies. CONCLUSIONS: This is the longest follow-up on a patient with anti-NMDAR encephalitis. Our findings emphasize that intrathecal antibody synthesis does not necessarily reflect disease activity and that the significance of NMDAR antibody titers needs to be interpreted for each patient according to the clinical context.
BACKGROUND: Anti- N-methyl-D-aspartate receptor (NMDAR) encephalitis is a severe autoimmune disorder characterized by high intrathecal antibody synthesis. Little is known about the long-term follow-up of the cerebrospinal fluid antibody status. OBJECTIVE: To describe persistent intrathecal antibody synthesis in a clinically healthy person 15 years after recovering from anti-NMDAR encephalitis. DESIGN: Case report. SETTING: Academic medical center. PATIENT: A 40-year-old woman who had been diagnosed as having encephalitis of unknown origin in 1995. MAIN OUTCOME MEASURES: Clinical evaluation and NMDAR antibody testing. RESULTS: On reexamination in 2011, the patient had fully recovered. Investigation of archived as well as follow-up serum and cerebrospinal fluid samples revealed intrathecal synthesis of NMDAR antibodies. CONCLUSIONS: This is the longest follow-up on a patient with anti-NMDAR encephalitis. Our findings emphasize that intrathecal antibody synthesis does not necessarily reflect disease activity and that the significance of NMDAR antibody titers needs to be interpreted for each patient according to the clinical context.
Authors: I Gabilondo; A Saiz; L Galán; V González; R Jadraque; L Sabater; A Sans; A Sempere; A Vela; F Villalobos; M Viñals; P Villoslada; F Graus Journal: Neurology Date: 2011-08-24 Impact factor: 9.910
Authors: E Martinez-Hernandez; J Horvath; Y Shiloh-Malawsky; N Sangha; M Martinez-Lage; J Dalmau Journal: Neurology Date: 2011-07-27 Impact factor: 9.910
Authors: Josep Dalmau; Erdem Tüzün; Hai-yan Wu; Jaime Masjuan; Jeffrey E Rossi; Alfredo Voloschin; Joachim M Baehring; Haruo Shimazaki; Reiji Koide; Dale King; Warren Mason; Lauren H Sansing; Marc A Dichter; Myrna R Rosenfeld; David R Lynch Journal: Ann Neurol Date: 2007-01 Impact factor: 10.422
Authors: H Prüss; J Dalmau; L Harms; M Höltje; G Ahnert-Hilger; K Borowski; W Stoecker; K P Wandinger Journal: Neurology Date: 2010-11-09 Impact factor: 9.910
Authors: Sarosh R Irani; Katarzyna Bera; Patrick Waters; Luigi Zuliani; Susan Maxwell; Michael S Zandi; Manuel A Friese; Ian Galea; Dimitri M Kullmann; David Beeson; Bethan Lang; Christian G Bien; Angela Vincent Journal: Brain Date: 2010-06 Impact factor: 13.501
Authors: Anne Waschbisch; Bernd Kallmünzer; Stefan Schwab; Philipp Gölitz; Angela Vincent; De-Hyung Lee; Ralf A Linker Journal: BMC Res Notes Date: 2014-12-23
Authors: Susanne Fauser; Ingo Uttner; Helena Ariño; Werner A Scherbaum; Albert Saiz; Jan Lewerenz Journal: BMC Neurol Date: 2015-09-30 Impact factor: 2.474